Hendra virus treatment to be ready in a few months

Dr Ananya Mandal, MD

Of the dozen people who were exposed to a horse infected with the Hendra virus, 11 have been cleared of the infection by repeated tests on Queensland's Sunshine Coast. These 12 people had first come into contact with the infected horse at Tewantin in May and have since then been subjected to testing to rule out infection with the deadly virus. It is expected that the 12th person will also be cleared soon. Quarantine restrictions were also lifted last month.

In yet another development, researchers from Queensland are working towards a successful human treatment of Hendra virus infection that will be ready in another six months time. The new treatment will have monoclonal antibodies against the virus. In May Sunshine Coast woman Rebecca Day and her 12-year-old daughter Mollie were given this drug as a trial. The mother and daughter duo were exposed to the virus from their horse. The only other person to have received the monoclonal antibody therapy was veterinarian Dr Alistair Rodgers, who died last year from the virus.

Hendra virus usually spreads from bats to horses and then to humans. Four of the seven exposed have died. Symptoms of Hendra virus in humans include flu-like illness, brain inflammation, high fevers, headache and drowsiness. There have been 14 Hendra outbreaks in Australia since 1994, killing more than 40 horses. All of the human deaths have happened in Queensland. Now the CSIRO is also working on a vaccine for horses

According to Queensland Health chief medical officer Jeannette Young the drug, originally developed in the US is still in its preliminary stages and has not been tested on humans extensively. However its efficacy has been proved in ferrets and monkeys. She emphasized that prevention is the key stone. She said, “It wasn't produced under the conditions that we would normally want a human therapy to be produced under… It's not an alternative to prevention. The best way is (for people) to protect themselves from horses.”

University of Queensland professor Paul Gray explained that the cell line was acquired from the US and the team was working towards 99.995 per cent pure human antibodies. He said, “We will get a preparation that is world-standard in respect to purity…We're working up a process so we can make large amounts in the future, if we needed it.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Hendra virus treatment to be ready in a few months. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20100714/Hendra-virus-treatment-to-be-ready-in-a-few-months.aspx.

  • MLA

    Mandal, Ananya. "Hendra virus treatment to be ready in a few months". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20100714/Hendra-virus-treatment-to-be-ready-in-a-few-months.aspx>.

  • Chicago

    Mandal, Ananya. "Hendra virus treatment to be ready in a few months". News-Medical. https://www.news-medical.net/news/20100714/Hendra-virus-treatment-to-be-ready-in-a-few-months.aspx. (accessed November 24, 2024).

  • Harvard

    Mandal, Ananya. 2018. Hendra virus treatment to be ready in a few months. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20100714/Hendra-virus-treatment-to-be-ready-in-a-few-months.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Metagenomic sequencing improves detection of rare pathogens in CNS infections